Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.5M
-
Number of holders
-
91
-
Total shares
-
8.7M
-
Shares change
-
-543K
-
Total reported value, excl. options
-
$730M
-
Value change
-
-$45.7M
-
Number of buys
-
34
-
Number of sells
-
-53
-
Price
-
$83.90
Significant Holders of LEMAITRE VASCULAR INC - Common Stock (LMAT) as of Q1 2025
102 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock as of Q1 2025.
LEMAITRE VASCULAR INC - Common Stock (LMAT) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.7M shares
of 22.5M outstanding shares and own 38.68% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (3.59M shares), Conestoga Capital Advisors, LLC (1.64M shares), Copeland Capital Management, LLC (1.08M shares), CONGRESS ASSET MANAGEMENT CO (644K shares), ENVESTNET ASSET MANAGEMENT INC (285K shares), RICE HALL JAMES & ASSOCIATES, LLC (211K shares), Bank of New York Mellon Corp (170K shares), PRINCIPAL FINANCIAL GROUP INC (112K shares), VICTORY CAPITAL MANAGEMENT INC (79.9K shares), and SEGALL BRYANT & HAMILL, LLC (76.5K shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.